Trial intelligence / Profile preview

Effects of mannitol on delayed graft function after kidney transplantation

2014-005391-29Phase 4Completed

Sponsor
Medical University of Vienna
Start
Jun 2015
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4 trial of Bronchitol in end-stage kidney disease (ESKD) and kidney transplant, sponsored by Medical University of Vienna. Primary endpoint: Biomarker panel (xMAP Luminex multi-analyte profiling). Started Jun 2015; status: completed.

02

Drugs

Bronchitol
03

Conditions

end-stage kidney disease (ESKD)kidney transplant

Beyond the preview

Go deeper on 2014-005391-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005391-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call